ArticleFrontiers in oncology2022

A Molecularly Characterized Preclinical Platform of Subcutaneous Renal Cell Carcinoma (RCC) Patient-Derived Xenograft Models to Evaluate Novel Treatment Strategies.

Dennis Gürgen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.